Cercar
01/01/2023
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis
Labidi-Galy S.I., Rodrigues M., Sandoval J.L., Kurtz J.E., Heitz F., Mosconi A.M., Romero I., Denison U., Nagao S., Vergote I., Parma G., Nøttrup T.J., Rouleau E., Garnier G., El-Balat A., Zamagni C., Martín-Lorente C., Pujade-Lauraine E., Fiévet A., Ray-Coquard I.L.. Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. ANNALS OF ONCOLOGY. 2023; 34(2)DOI:10.1016/j.annonc.2022.11.003. PMID:36564284. IF:56.700(Q1/1D).
01/01/2023
Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer
Garcia N.G., Moreno C.S., Teixeira N., Lloret P.E., Guibourg R., Negre R.R.. Comparison of laparoscopy and laparotomy in the management of early-stage ovarian cancer. GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT. 2023; 12(2)DOI:10.4103/gmit.gmit_99_22. PMID:37416098. IF:(Q/D).
01/01/2023
A Reappraisal of Lymphadenectomy in Common Gynecological Cancers
Habib N., Moufawad G., Hayek J., Futcher F., Chiantera V., Negre R.R., Devassy R., Centini G., Mereu L.. A Reappraisal of Lymphadenectomy in Common Gynecological Cancers. Clinical and Experimental Obstetrics & Gynecology. 2023; 50(9)DOI:10.31083/j.ceog5009181. PMID:. IF:0.400(Q4/9D).
01/01/2023
How have quality newspapers covered the microbiome? A content analysis of The New York Times, The Times, and El Pais
Prados-Bo, A, Casino, G. How have quality newspapers covered the microbiome? A content analysis of The New York Times, The Times, and El Pais. Journalism. 2023; 24(8)DOI:10.1177/14648849211067858. PMID:. IF:2.700(Q1/2D).